Yang Yi-min, Li Qian-ning, Ying Da-jun, Gong Zi-li, Cheng Rong-chuan, Lü Min, Liu Yong, Zhou Zhu-juan, Zheng Jian
The Department of Neurology, Xinqiao Hospital, The Third Military Medical University, Chongqing 400037, China.
Yao Xue Xue Bao. 2006 Sep;41(9):808-13.
To study the effect of antiparallel phosphorothioate triplex-forming oligonucleotide (apsTFO) matching with the shear stress response element (SSRE) of tissue factor (TF) gene promoter region on the expression of TF in endothelial cells (ECs) of rat common carotid artery stenosis.
The model of common carotid artery middle segment stenosis was established by silica gel pipe loop ligation in SD rats. The mRNA expression and protein synthesis of TF, early growth response-1 (Egr-1) and specificity protein 1 (Sp1) were measured by in situ hybridization (ISH) and immunohistochemistry (IHC) technique. GT21-apsTFO, GT20-apsTFO, GT20-psTFO and FITC-labeled apsTFO, matching with the SSRE of TF gene promoter region, were designed, and intravenously injected into rats at 0.5 h before operation. TFO was detected 4 h after the operation, and the mRNA expression and protein synthesis of TF, Egr-1 and Sp1 were detected 6 h after the operation.
There were much fluorescence in vascular tissue, especially in the nuclear of ECs 4.5 h after the injection of apsTFO. The mRNA expression and protein synthesis of TF reduced by 22% - 23% with injection of GT20-apsTFO 6.5 h after stenosis (P < 0.01) and by 10% - 11% with GT21-apsTFO at the same time (P < 0.05). The inhibition by GT20-apsTFO was stronger than that of the GT21-apsTFO (P < 0.05). The expression of TF was not inhibited by the GT20-psTFO (P > 0.05). The mRNA expression and protein synthesis of Egr-1 and Sp1 did not change in the rat treated with GT20-apsTFO, GT20-psTFO and GT21-apsTFO (P > 0.05).
apsTFO could mero-inhibit the expression of TF gene but could not change the expression of Egr-1 and Sp1 protein.
研究与组织因子(TF)基因启动子区域的剪切应力反应元件(SSRE)匹配的反平行硫代磷酸三链形成寡核苷酸(apsTFO)对大鼠颈总动脉狭窄内皮细胞(ECs)中TF表达的影响。
采用硅胶管环扎法建立SD大鼠颈总动脉中段狭窄模型。通过原位杂交(ISH)和免疫组织化学(IHC)技术检测TF、早期生长反应因子-1(Egr-1)和特异性蛋白1(Sp1)的mRNA表达和蛋白合成。设计与TF基因启动子区域的SSRE匹配的GT21-apsTFO、GT20-apsTFO、GT20-psTFO和异硫氰酸荧光素(FITC)标记的apsTFO,并在手术前0.5小时静脉注射到大鼠体内。术后4小时检测TFO,术后6小时检测TF、Egr-1和Sp1的mRNA表达和蛋白合成。
注射apsTFO后4.5小时,血管组织中出现大量荧光,尤其是在内皮细胞核中。狭窄后6.5小时注射GT20-apsTFO,TF的mRNA表达和蛋白合成降低了22% - 23%(P < 0.01),同时注射GT21-apsTFO降低了10% - 11%(P < 0.05)。GT20-apsTFO的抑制作用强于GT21-apsTFO(P < 0.05)。GT20-psTFO未抑制TF的表达(P > 0.05)。用GT20-apsTFO、GT20-psTFO和GT21-apsTFO处理的大鼠中,Egr-1和Sp1的mRNA表达和蛋白合成没有变化(P > 0.05)。
apsTFO可部分抑制TF基因的表达,但不改变Egr-1和Sp1蛋白的表达。